Credit: Matt Miller/Washington University
Kanta Horie, PhD, (left) and Chihiro Sato, PhD, discuss data in the Tracy Family SILQ Center at Washington University School of Medicine in St. Louis. Sato and Horie led a team that discovered a biomarker for a rare, deadly brain disease known as corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD.